about
Clinical outcome measures in juvenile idiopathic arthritisThe joints in juvenile idiopathic arthritisTowards a role of ultrasound in children with juvenile idiopathic arthritis.Long-term safety of immunomodulators in pediatric inflammatory diseases.Regulation of Human Macrophage M1-M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1.Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease.
P2860
Q26752701-F2D5D716-956B-4703-A75B-4AC34E52ED36Q35650440-CFFE1699-7ADD-4D02-824E-E7421807206EQ38059101-202D5DD6-EB59-479E-8917-06AFC6059A77Q38232338-2E0335E0-DCCF-45EC-9AA1-ED7F2C51ED0BQ41313325-FAC1E947-8E99-4488-940A-398177A2909EQ44541879-01984DFD-48AE-4AAF-9CDF-6E12A8D92358Q52617055-F33DD155-CC0A-478E-8B4A-33E680812804
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging drugs to treat juvenile idiopathic arthritis.
@en
Emerging drugs to treat juvenile idiopathic arthritis.
@nl
type
label
Emerging drugs to treat juvenile idiopathic arthritis.
@en
Emerging drugs to treat juvenile idiopathic arthritis.
@nl
prefLabel
Emerging drugs to treat juvenile idiopathic arthritis.
@en
Emerging drugs to treat juvenile idiopathic arthritis.
@nl
P2860
P1476
Emerging drugs to treat juvenile idiopathic arthritis.
@en
P2093
Alberto Martini
P2860
P304
P356
10.1517/14728214.2011.581662
P407
P577
2011-04-30T00:00:00Z